The potential role of O-GlcNAc modification in cancer epigenetics

[1] Goldberg, A.D., Allis, C.D. and Bernstein, E. Epigenetics: A landscape takes shape. Cell 128 (2007) 635–638. Search in Google Scholar

[2] Ducasse, M. and Brown, M.A. Epigenetic aberrations and cancer. Mol. Cancer 5 (2006) 60. Search in Google Scholar

[3] Sharma, S., Kelly, T.K. and Jones, P.A. Epigenetics in cancer. Carcinogenesis 31 (2010) 27–36. Search in Google Scholar

[4] Ellis, L., Atadja, P.W. and Johnstone, R.W. Epigenetics in cancer: targeting chromatin modifications. Mol. Cancer Ther. 8 (2009) 1409–1420. 10.1158/1535-7163.MCT-08-0860Search in Google Scholar PubMed

[5] Lim, U. and Song, M.A. Dietary and lifestyle factors of DNA methylation. Methods Mol. Biol. 863 (2012) 359–376. Search in Google Scholar

[6] Herceg, Z. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 22 (2007) 91–103. Search in Google Scholar

[7] Hardy, T.M. and Tollefsbol, T.O. Epigenetic diet: impact on the epigenome and cancer. Epigenomics 3 (2011) 503–518. 10.2217/epi.11.71Search in Google Scholar PubMed PubMed Central

[8] Jiménez-Chillarón, J.C., Díaz, R., Martínez, D., Pentinat, T., Ramón-Krauel, M., Ribó, S. and Plösch, T. The role of nutrition on epigenetic modifications and their implications on health. Biochimie 94 (2012) 2242–2263. Search in Google Scholar

[9] Roberts, D.L., Dive, C. and Renehan, A.G. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu. Rev. Med. 61 (2010) 301–316. 10.1146/annurev.med.080708.082713Search in Google Scholar PubMed

[10] Simon, D. and Balkau, B. Diabetes mellitus, hyperglycaemia and cancer. Diabetes Metab. 36 (2010) 182–191. 10.1016/j.diabet.2010.04.001Search in Google Scholar PubMed

[11] Bensinger, S.J. and Christofk, H.R. New aspects of the Warburg effect in cancer cell biology. Semin. Cell Dev. Biol. 23 (2012) 352–361. Search in Google Scholar

[12] Dang, C.V. Links between metabolism and cancer. Genes Dev. 26 (2012) 877–890. Search in Google Scholar

[13] Krzeslak, A., Wojcik-Krowiranda, K., Forma, E., Jozwiak, P., Romanowicz, H., Bienkiewicz, A. and Brys, M. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers. Pathol. Oncol. Res. 18 (2012) 721–728. Search in Google Scholar

[14] Jóźwiak, P., Krześlak, A., Pomorski, L. and Lipińska, A. Expression of hypoxia-related glucose transporters GLUT1 and GLUT3 in benign, malignant and non-neoplastic thyroid lesions. Mol. Med. Rep. 6 (2012) 601–606. Search in Google Scholar

[15] Jóźwiak, P. and Lipińska, A. The role of glucose transporter 1 (GLUT1) in the diagnosis and therapy of tumors. Post. Hig. Med. Dosw. 66 (2012) 165–174. Search in Google Scholar

[16] Szablewski, L. Expression of glucose transporters in cancers. Biochim. Biophys. Acta 1835, (2013) 164–169. 10.1016/j.bbcan.2012.12.004Search in Google Scholar PubMed

[17] Butkinaree, C., Park, K. and Hart, G.W. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim. Biophys. Acta 1800 (2010) 96–106. Search in Google Scholar

[18] Slawson, C., Copeland, R.J. and Hart, G.W. O-GlcNAc signaling: a metabolic link between diabetes and cancer? Trends Biochem. Sci. 35 (2010) 547–555. Search in Google Scholar

[19] Hanover, J.A., Krause, M.W. and Love, D.C. The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim. Biophys. Acta 1800 (2010) 80–95. Search in Google Scholar

[20] Slawson, C. and Hart, G.W. O-GlcNAc signalling: implications for cancer cell biology. Nat. Rev. Cancer 11 (2011) 678–684. 10.1038/nrc3114Search in Google Scholar PubMed PubMed Central

[21] Vocadlo, D.J. O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulation. Curr. Opin. Chem. Biol. 16 (2012) 488–497. Search in Google Scholar

[22] Bullen, J.W., Balsbaugh, J.L., Chanda, D., Shabanowitz, J., Hunt, D.F., Neumann, D. and Hart, G.W. Cross-talk between two essential nutrientsensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK). J. Biol. Chem. 289 (2014) 10592–606. DOI: 10.1074/jbc.M113. Search in Google Scholar

[23] Xu, Q., Yang, C., Du, Y., Chen, Y., Liu, H., Deng, M., Zhang, H., Zhang, L., Liu, T., Liu, Q., Wang, L., Lou, Z. and Pei, H. AMPK regulates histone H2B O-GlcNAcylation. Nucleic Acids Res. (2014) DOI: 10.1093/nar/gku236. 10.1093/nar/gku236Search in Google Scholar PubMed PubMed Central

[24] Hu, P., Shimoji, S. and Hart, G.W. Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation. FEBS Lett. 584 (2010) 2526–2538. Search in Google Scholar

[25] Özcan, S., Andrali, S.S. and Cantrell, J.E. Modulation of transcription factor function by O-GlcNAc modification. Biochim. Biophys. Acta 1799 (2010) 353–364. Search in Google Scholar

[26] Ruan, H.B., Singh, J.P., Li, M.D., Wu, J. and Yang, X. Cracking the O-GlcNAc code in metabolism. Trends Endocrinol. Metab. 24 (2013) 301–309. 10.1016/j.tem.2013.02.002Search in Google Scholar PubMed PubMed Central

[27] Hart, G.W., Slawson, C., Ramirez-Correa, G. and Lagerlof, O. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu. Rev. Biochem. 80 (2011) 825–858. Search in Google Scholar

[28] Onodera, Y., Nam, J.M. and Bissell, M.J. Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways. J. Clin. Invest. (2013) DOI: 10.1172/JCI63146. 10.1172/JCI63146Search in Google Scholar PubMed PubMed Central

[29] Li, Z. and Yi, W. Regulation of cancer metabolism by O-GlcNAcylation. Glycoconj. J. (2013) DOI 10.1007/s10719-013-9515-5. Search in Google Scholar

[30] Mi, W., Gu, Y., Han, C., Liu, H., Fan, Q., Zhang, X., Cong, Q., and Yu, W. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Biochim. Biophys. Acta 1812 (2011) 514–519. Search in Google Scholar

[31] Lynch, T.P., Ferrer, C.M., Jackson, S.R., Shahriari, K.S., Vosseller, K. and Reginato, M.J. Crtical role of O-linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J. Biol. Chem. 287 (2012) 11070–11081. 10.1074/jbc.M111.302547Search in Google Scholar PubMed PubMed Central

[32] Caldwell, S.A., Jackson, S.R., Shahriari, K.S., Lynch, T.P., Sethi, G., Walker, S., Vosseller, K. and Reginato, M.J. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 29 (2010) 2831–2842. Search in Google Scholar

[33] Gu, Y., Mi, W., Ge, Y., Liu, H., Fan, Q., Han, C., Yang, J., Han, F., Lu, X. and Yu, W. GlcNAcylation plays an essential role in breast cancer metastasis. Cancer Res. 70 (2010) 6344–6351. Search in Google Scholar

[34] Yehezkel, G., Cohen, L., Kliger, A., Manor, E. and Khalaila, I. O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) in primary and metastatic colorectal cancer clones and effect of N-acetyl-β-D-glucosaminidase silencing on cell phenotype and transcriptome. J. Biol. Chem. 287 (2012) 28755–28769. Search in Google Scholar

[35] Phueaouan, T., Chaiyawat, P., Netsirisawan, P., Chokchaichamnankit, D., Punyarit, P., Srisomsap, C., Svasti, J. and Champattanachai, V. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer. Oncol. Rep. 30 (2013) 2929–2936. Search in Google Scholar

[36] Zhu, Q., Zhou, L., Yang, Z., Lai, M., Xie, H., Wu, L., Xing, C., Zhang, F. and Zheng, S. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Med. Oncol. 29 (2012) 985–993. Search in Google Scholar

[37] Ma, Z. and Vosseller, K. O-GlcNAc in cancer biology. Amino Acids 45 (2013) 719–733. 10.1007/s00726-013-1543-8Search in Google Scholar PubMed

[38] Shi, Y., Tomic, J., Wen, F., Shaha, S., Bahlo, A., Harrison, R., Dennis, J.W., Williams, R., Gross, B.J. and Walker, S. Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. Leukemia 24 (2010) 1588–1598. Search in Google Scholar

[39] Krześlak, A., Forma, E., Bernaciak, M., Romanowicz, H. and Bryś, M. Gene expression of O-GlcNAc cycling enzymes in human breast cancers. Clin. Exp. Med. 12 (2012) 61–65. Search in Google Scholar

[40] Krześlak, A., Wójcik-Krowiranda, K., Forma, E., Bieńkiewicz, A., Bryś, M. Expression of genes encoding for enzymes associated with O-GlcNAcylation in endometrial carcinomas: clinicopathologic correlations. Ginekol. Pol. 83 (2012) 22–26. Search in Google Scholar

[41] Rozanski, W., Krześlak, A., Forma, E., Bryś, M., Blewniewski, M., Wozniak, P., and Lipinski, M. Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level. Clin. Lab. 58 (2012) 579–583. Search in Google Scholar

[42] Champattanachai, V., Netsirisawan, P., Chaiyawat, P., Phueaouan, T., Charoenwattanasatien, R., Chokchaichamnankit, D., Punyarit, P., Srisomsap, C. and Svasti, J. Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer. Proteomics 13 (2013) 2088–2099. Search in Google Scholar

[43] Fardini, Y., Dehennaut, V., Lefebvre, T. and Issad, T. O-GlcNAcylation: a new cancer hallmark? Front. Endocrinol. 4 (2013) 99. Search in Google Scholar

[44] Wang, Z., Udeshi, N.D., Slawson, C., Compton, P.D., Sakabe, K., Cheung, W.D., Shabanowitz, J., Hunt, D.F. and Hart, G.W. Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci. Signal. 3 (2010) ra2. DOI: 10.1126/scisignal.2000526. 10.1126/scisignal.2000526Search in Google Scholar PubMed PubMed Central

[45] Krześlak, A., Jóźwiak, P. and Lipińska, A. Down-regulation of β-N-acetyl-D-glucosaminidase increases Akt1 activity in thyroid anaplastic cancer cells. Oncol. Rep. 26 (2011) 743–749. Search in Google Scholar

[46] Huang, X., Pan, Q., Sun, D., Chen, W., Shen, A., Huang, M., Ding, J. and Geng, M. O-GlcNAcylation of cofilin promotes breast cancer cell invasion. J. Biol. Chem. 288 (2013) 36418–36425. Search in Google Scholar

[47] Park, S.Y., Kim, H.S., Kim, N.H., Ji, S., Cha, S.Y., Kang, J.G., Ota, I., Shimada, K., Konishi, N. and Nam, H.W. Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition. EMBO J. 29 (2010) 3787–3796. Search in Google Scholar

[48] Thiery, J.P., Acloque, H., Huang, R.Y. and Nieto, M.A. Epithelialmesenchymal transitions in development and disease. Cell 139 (2009) 871–890. Search in Google Scholar

[49] Zhu, W., Leber, B. and Andrews, D.W. Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis. EMBO J. 20 (2001) 5999–6007. Search in Google Scholar

[50] Jin, F.Z., Yu, C., Zhao, D.Z., Wu, M.J. and Yang, Z. A correlation between altered O-GlcNAcylation, migration and with changes in E-cadherin levels in ovarian cancer cells. Exp. Cell. Res. 319 (2013) 1482–1490. Search in Google Scholar

[51] Kanwal, R. and Gupta, S. Epigenetic modifications in cancer. Clin. Genet. 81 (2012) 303–311. Search in Google Scholar

[52] Hassler, M.R. and Egger, G. Epigenomics of cancer — emerging new concepts. Biochimie 94 (2012) 2219–2230. Search in Google Scholar

[53] Tsai, H.C. and Baylin S.B. Cancer epigenetics: linking basic biology to clinical medicine. Cell Res. 21 (2011) 502–517. Search in Google Scholar

[54] Sakabe, K., Wang, Z. and Hart, G.W. Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc. Natl. Acad. Sci. USA 107 (2010) 19915–19920. Search in Google Scholar

[55] Zhang, S., Roche, K., Nasheuer, H.P. and Lowndes, N.F. Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated. J. Biol. Chem. 286 (2011) 37483–37495. Search in Google Scholar

[56] Fujiki, R., Hashiba, W., Sekine, H., Yokoyama, A., Chikanishi, T., Ito, S., Imai, Y., Kim, J., He, H.H., Igarashi, K., Kanno, J., Ohtake, F., Kitagawa, H., Roeder, R.G., Brown, M. and Kato, S. GlcNAcylation of histone H2B facilitates its monoubiquitination. Nature 480 (2011) 557–560. Search in Google Scholar

[57] Fong, J.J., Nguyen, B.L., Bridger, R., Medrano, E.E., Wells, L., Pan, S. and Sifers RN. β-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3. J. Biol. Chem. 287 (2012) 12195–12203. Search in Google Scholar

[58] Gao, Z. and Xu, C.W. Glucose metabolism induces mono-ubiquitination of histone H2B in mammalian cells. Biochem. Biophys. Res. Commun. 404 (2011) 428–433. Search in Google Scholar

[59] Urasaki, Y., Heath, L. and Xu, C.W. Coupling of glucose deprivation with impaired histone H2B monoubiquitination in tumors. PLoS One 7 (2012) e36775. 10.1371/journal.pone.0036775Search in Google Scholar PubMed PubMed Central

[60] Shema, E., Tirosh, I., Aylon, Y., Huang, J., Ye, C., Moskovits, N., Raver-Shapira, N., Minsky, N., Pirngruber, J., Tarcic, G., Hublarova, P., Moyal, L., Gana-Weisz, M., Shiloh, Y., Yarden, Y., Johnsen, S.A., Vojtesek, B., Berger, S.L. and Oren M. The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes Dev. 22 (2008) 2664–2676. Search in Google Scholar

[61] Chernikova, S.B., Razorenova, O.V., Higgins, J.P., Sishc, B.J., Nicolau, M., Dorth, J.A., Chernikova, D.A., Kwok, S., Brooks, J.D., Bailey, S.M., Game, J.C. and Brown J.M. Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability. Cancer Res. 72 (2012) 2111–2119. Search in Google Scholar

[62] Chen, Q., Chen, Y., Bian, C., Fujiki, R. and Yu, X. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 493 (2013) 561–564. Search in Google Scholar

[63] Deplus, R., Delatte, B., Schwinn, M.K., Defrance, M., Méndez, J., Murphy, N., Dawson, M.A., Volkmar, M., Putmans, P., Calonne, E., Shih, A.H., Levine, R.L., Bernard, O., Mercher, T., Solary, E., Urh, M., Daniels, D.L. and Fuks, F. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J. 32 (2013) 645–655. Search in Google Scholar

[64] Sakabe, K. and Hart, G.W. O-GlcNAc transferase regulates mitotic chromatin dynamics. J. Biol. Chem. 285 (2010) 34460–34468. Search in Google Scholar

[65] Baek, S.H. When signaling kinases meet histones and histone modifiers in the nucleus. Mol. Cell 42 (2011) 274–284. Search in Google Scholar

[66] Nowak, S.J. and Corces, V.G. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet. 20 (2004) 214–220. Search in Google Scholar

[67] Choi, H.S., Choi, B.Y., Cho, Y.Y., Mizuno, H., Kang, B.S., Bode, A.M. and Dong, Z. Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation. Cancer Res. 65 (2005) 5818–5827. Search in Google Scholar

[68] Zippo, A., De Robertis, A., Serafini, R. and Oliviero, S. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nat. Cell. Biol. 9 (2007) 932–944. Search in Google Scholar

[69] Chadee, D.N., Hendzel, M.J., Tylipski, C.P., Allis, C.D., Bazett-Jones, D.P., Wright, J.A. and Davie, J.R. Increased Ser-10 phosphorylation of histone H3 in mitogen stimulated and oncogene-transformed mouse fibroblasts. J. Biol. Chem. 274 (1999) 24914–24920. Search in Google Scholar

[70] Strelkov, I.S. and Davie, J.R. Ser-10 phosphorylation of histone H3 and immediate early gene expression in oncogene-transformed mouse fibroblasts. Cancer Res. 62 (2002) 75–78. Search in Google Scholar

[71] Kim, H.G., Lee, K.W., Cho, Y.Y., Kang, N.J., Oh, S.M., Bode, A.M. and Dong, Z. Mitogen and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation. Cancer Res. 68 (2008) 2538–2547. Search in Google Scholar

[72] Tange, S., Ito, S., Senga, T. and Hamaguchi, M. Phosphorylation of histone H3 at Ser10: its role in cell transformation by v-Src. Biochem. Biophys. Res. Commun. 386 (2009) 588–592. 10.1016/j.bbrc.2009.06.082Search in Google Scholar PubMed

[73] Portella, G., Passaro, C. and Chieffi, P. Aurora B: a new prognostic marker and therapeutic target in cancer. Curr. Med. Chem. 18 (2011) 482–496. Search in Google Scholar

[74] Murnion, M.E., Adams, R.R., Callister, D.M., Allis, C.D., Earnshaw, W.C. and Swedlow, J.R. Chromatin-associated protein phosphatase 1 regulates aurora-B and histone H3 phosphorylation. J. Biol. Chem. 276 (2001) 26656–26665. Search in Google Scholar

[75] Wells, L., Kreppel, L.K., Comer, F.I., Wadzinski, B.E. and Hart, G.W. O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits. J. Biol. Chem. 279 (2004) 38466–38470. Search in Google Scholar

[76] Slawson, C., Lakshmanan, T., Knapp, S., Hart, G.W. A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin. Mol. Biol. Cell 19 (2008) 4130–4140. Search in Google Scholar

[77] Tan, E.P., Caro, S., Potnis, A., Lanza, C. and Slawson, C. O-linked N-acetylglucosamine cycling regulates mitotic spindle organization. J. Biol. Chem. 288 (2013) 27085–27099. Search in Google Scholar

[78] Capotosti, F., Guernier, S., Lammers, F., Waridel, P., Cai, Y., Jin, J., Conaway, J.W., Conaway, R.C. and Herr, W. O-GlcNAc transferase catalyzes site-specific proteolysis of HCF-1. Cell 144 (2011) 376–388. Search in Google Scholar

[79] Hanover, JA. A versatile sugar transferase makes the cut. Cell 144 (2011) 321–322. Search in Google Scholar

[80] Coller, H.A. Is cancer a metabolic disease? Am. J. Pathol. 184 (2014) 4–17. Search in Google Scholar

[81] Ruan, H.B., Han, X., Li, M.D., Singh, J.P., Qian, K., Azarhoush, S., Zhao, L., Bennett, A.M., Samuel, V.T., Wu, J., Yates, J.R. 3rd and Yang, X. O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability. Cell Metab. 16 (2012) 226–237. DOI: 10.1016/j.cmet.2012.07.006. 10.1016/j.cmet.2012.07.006Search in Google Scholar PubMed PubMed Central

[82] Zargar, Z.U. and Tyagi, S. Role of host cell factor-1 in cell cycle regulation. Transcription 34 (2012) 187–192. Search in Google Scholar

[83] Glinsky, G.V., Berezovska, O. and Glinskii, A.B. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 115 (2005) 1503–1521. Search in Google Scholar

[84] Julien, E. and Herr, W. Proteolytic processing is necessary to separate an ensure proper cell growth and cytokinesis functions of HCF-1. EMBO J. 22 (2003) 2360–2369. Search in Google Scholar

[85] Julien, E. and Herr, W. A switch in mitotic histone H4 lysine 20 methylation status is linked to M phase defects upon loss of HCF1. Mol. Cell 14 (2004) 713–725. Search in Google Scholar

[86] Tyagi, S. and Herr, W. E2F mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferase. EMBO J. 28 (2009) 3185–3195. Search in Google Scholar

[87] Wysocka, J., Myers, M.P., Laherty, C.D., Eisenman, R.N. and Herr, W. Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1. Genes Dev. 17 (2003) 896–911. Search in Google Scholar

[88] Mazars, R., Gonzalez-de-Peredo, A., Cayrol, C., Lavigne, A.C., Vogel, J.L., Ortega, N., Lacroix, C., Gautier, V., Huet, G., Ray, A., Monsarrat, B., Kristie, T.M. and Girard, J.P. The THAP-zinc finger protein THAP1 associates with coactivator HCF-1 and O-GlcNAc transferase: a link between DYT6 and DYT3 dystonias. J. Biol. Chem. 285 (2010) 13364–13371. Search in Google Scholar

[89] Daou, S., Mashtalir, N., Hammond-Martel, I., Pak, H., Yu, H., Sui, G., Vogel, J.L., Kristie, T.M. and Affar el, B. Crosstalk between OGlcNAcylation and proteolytic cleavage regulates the host cell factor-1 maturation pathway. Proc. Natl. Acad. Sci. USA 108 (2011) 2747–2752. Search in Google Scholar

[90] Lazarus, M.B., Jiang, J., Kapuria, V., Bhuiyan, T., Janetzko, J., Zandberg, W.F., Vocadlo, D.J., Herr, W. and Walker, S. HCF-1 is cleaved in the active site of O-GlcNAc transferase. Science 342 (2013) 1235–1239. Search in Google Scholar

[91] Reilly, P.T., Wysocka, J. and Herr, W. Inactivation of the retinoblastoma protein family can bypass the HCF-1 defect in tsBN67 cell proliferation and cytokinesis. Mol. Cell. Biol. 22 (2002) 6767–6778. Search in Google Scholar

[92] Wells, L., Slawson, C. and Hart, G.W. The E2F-1 associated retinoblastomasusceptibility gene product is modified by O-GlcNAc. Amino Acids 40 (2011) 877–883. Search in Google Scholar

[93] Murali, R., Wiesner, T. and Scolyer, R.A. Tumors associated with BAP1 mutations. Pathology 45 (2013) 116–126. Search in Google Scholar

[94] Dey, A., Seshasayee, D., Noubade, R., French, D.M., Liu, J., Chaurushiya, M.S., Kirkpatrick, D.S., Pham, V.C., Lill, J.R., Bakalarski, C.E., Wu, J., Phu, L., Katavolos, P., LaFave, L.M., Abdel-Wahab, O., Modrusan, Z., Seshagiri, S., Dong, K,. Lin, Z., Balazs, M., Suriben, R., Newton, K., Hymowitz, S., Garcia-Manero, G., Martin, F., Levine, R.L. and Dixit V. M. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 337 (2012) 1541–1546. Search in Google Scholar

[95] Yang, X., Zhang, F. and Kudlow, J.E. Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Cell 110 (2002) 69–80. Search in Google Scholar

[96] Cayrol, C., Lacroix, C., Mathe, C., Ecochard, V., Ceribelli, M., Loreau, E., Lazar, V., Dessen, P., Mantovani, R., Aguilar, L. and Girard, J.P. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes. Blood 109 (2007) 584–594. Search in Google Scholar

[97] Macfarlan, T., Kutney, S., Altman, B., Montross, R., Yu, J., Chakravarti, D. and Girard, J.P. Human THAP7 is a chromatin-associated, histone tailbinding protein that represses transcription via recruitment of HDAC3 and nuclear hormone receptor corepressor. J. Biol. Chem. 280 (2005) 7346–7358. Search in Google Scholar

[98] Roussigne, M., Cayrol, C., Clouaire, T., Amalric, F. and Girard, J.P. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies. Oncogene 22 (2003) 2432–2442. Search in Google Scholar

[99] Zhu, C.Y., Li, C.Y., Li, Y., Zhan, Y.Q., Li, Y.H., Xu, C.W., Xu, W.X., Sun, H.B. and Yang, X.M. Cell growth suppression by thanatos-associated protein 11 (THAP11) is mediated by transcriptional downregulation of c-Myc. Cell Death Differ. 16 (2009) 395–405. Search in Google Scholar

[100] Dejosez, M., Krumenacker, J.S., Zitur, L.J., Passeri, M., Chu, L.F., Songyang, Z., Thomson, J.A. and Zwaka, T.P. Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells. Cell 133 (2008) 1162–1174. Search in Google Scholar

[101] Parker, J.B., Palchaudhuri, S., Yin, H., Wei, J. and Chakravarti, D.A. Transcriptional regulatory role of the THAP11-HCF-1 complex in colon cancer cell function. Mol. Cell. Biol. 32 (2012) 1654–1670. Search in Google Scholar

[102] Ito, S., D’Alessio, A.C., Taranova, O.V., Hong, K., Sowers, L.C. and Zhang, Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466 (2010) 1129–1133. Search in Google Scholar

[103] Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L.M., Liu, D.R., Aravind, L. and Rao, A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324 (2009) 930–935. Search in Google Scholar

[104] Kriaucionis, S. and Heintz, N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324 (2009) 929–930. Search in Google Scholar

[105] Pfeifer, G.P., Kadam, S. and Jin, S.G. 5-hydroxymethylcytosine and its potential roles in development and cancer. Epigenetics Chromatin. 6 (2013) 10. Search in Google Scholar

[106] Lorsbach, R.B., Moore, J., Mathew, S., Raimondi, S.C., Mukatira, S.T. and Downing, J.R. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 17 (2003) 637–641. Search in Google Scholar

[107] Delatte, B. and Fuks, F. TET proteins: on the frenetic hunt for new cytosine modifications. Brief Funct. Genomics 12 (2013) 191–204. 10.1093/bfgp/elt010Search in Google Scholar PubMed PubMed Central

[108] Tan, L. and Shi, Y.G. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 139 (2012) 1895–1902. Search in Google Scholar

[109] Jin, S.G, Jiang, Y., Qiu, R., Rauch, T.A., Wang, Y., Schackert, G., Krex, D., Lu, Q. and Pfeifer, G.P. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutation. Cancer Res. 71 (2011) 7360–7365. Search in Google Scholar

[110] Haffner, M.C., Chaux, A., Meeker, A.K., Esopi, D.M., Gerber, J., Pellakuru, L.G., Toubaji, A., Argani, P., Iacobuzio-Donahue, C., Nelson, W.G., Netto, G.J., De Marzo, A.M. and Yegnasubramanian, S. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 6 (2011) 627–637. Search in Google Scholar

[111] Yang, H., Liu, Y., Bai, F., Zhang, J.Y., Ma, S.H., Liu, J., Xu, Z.D., Zhu, H.G., Ling, Z.Q., Ye, D., Guan, K.L. and Xiong, Y. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 6 (2013) 663–669. Search in Google Scholar

[112] Kraus, T.F., Globisch, D., Wagner, M., Eigenbrod, S., Widmann, D., Munzel, M., Muller, M., Pfaffeneder, T., Hackner, B., Feiden, W., Schüller, U., Carell, T. and Kretzschmar, H.A. Low values of 5-hydroxymethylcytosine (5hmC), the “sixth base”, are associated with anaplasia in human brain tumors. Int. J. Cancer 6 (2012) 1577–1590. Search in Google Scholar

[113] Kudo, Y., Tateishi, K., Yamamoto, K., Yamamoto, S., Asaoka, Y., Ijichi, H., Nagae, G., Yoshida, H., Aburatani, H. and Koike, K. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci. 6 (2012) 670–676. Search in Google Scholar

[114] Lian, C.G., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., Lee, C.W., Hu, D., Lian, B.Q., Kleffel, S., Yang, Y., Neiswender, J., Khorasani, A.J., Fang, R., Lezcano, C., Duncan, L.M., Scolyer, R.A., Thompson, J.F., Kakavand, H., Houvras, Y., Zon, L.I., Mihm, M.C. Jr, Kaiser, U.B., Schatton, T., Woda, B.A., Murphy, G.F., Shi, Y.G. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 6 (2012) 1135–1146. Search in Google Scholar

[115] Ito, R., Katsura, S., Shimada, H., Tsuchiya, H., Hada, M., Okumura, T., Sugawara, A. and Yokoyama, A. TET3-OGT interaction increases the stability and the presence of OGT in chromatin. Genes Cells 19 (2014) 52–65. Search in Google Scholar

[116] Wu, H., D’Alessio, A.C., Ito, S., Xia, K., Wang, Z., Cui, K., Zhao, K., Sun, Y.E. and Zhang, Y. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 473 (2011) 389–393. Search in Google Scholar

[117] Williams, K., Christensen, J., Pedersen, M.T., Johansen, J.V., Cloos, P.A., Rappsilber, J. and Helin, K. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473 (2011) 343–348. Search in Google Scholar

[118] Shi, F.T., Kim, H., Lu, W., He, Q., Liu, D., Goodell, M.A., Wan, M. and Songyang, Z. Ten-eleven translocation 1 (Tet1) is regulated by O-linked N-acetylglucosamine transferase (Ogt) for target gene repression in mouse embryonic stem cells. J. Biol. Chem. 288 (2013) 20776–20784. Search in Google Scholar

[119] Yang, Q., Wu, K., Ji, M., Jin, W., He, N., Shi, B. and Hou, P. Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients. J. Biomed. Nanotechnol. 9 (2013) 1607–1616. Search in Google Scholar

[120] Fu, H.L., Ma, Y., Lu, L.G., Hou, P., Li, B.J., Jin, W.L. and Cui, D.X. TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer J. Biomed. Nanotechnol. 10 (2014) 1217–1230. Search in Google Scholar

[121] Hsu, C.H., Peng, K.L., Kang, M.L., Chen, Y.R., Yang, Y.C., Tsai, C.H., Chu, C.S., Jeng, Y.M., Chen, Y.T., Lin, F.M., Huang, H.D., Lu, Y.Y., Teng, Y.C., Lin, S.T., Lin, R.K., Tang, F.M., Lee, S.B., Hsu, H.M., Yu, J.C., Hsiao, P.W. and Juan, L.J. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep. 2 (2012) 568–579. DOI: 10.1016/j.celrep.2012.08.030. 10.1016/j.celrep.2012.08.030Search in Google Scholar PubMed

[122] Gambetta, M.C., Oktaba, K. and Müller, J. Essential role of the glycosyltransferase sxc/Ogt in polycomb repression. Science 325 (2009) 93–96. Search in Google Scholar

[123] Sinclair, D.A., Syrzycka, M., Macauley, M.S., Rastgardani, T., Komljenovic, I., Vocadlo, D.J., Brock, H.W. and Honda, B.M. Drosophila O-GlcNAc transferase (OGT) is encoded by the Polycomb group (PcG) gene, super sex combs (sxc). Proc. Natl. Acad. Sci. USA 106 (2009) 13427–13432. 10.1073/pnas.0904638106Search in Google Scholar PubMed PubMed Central

[124] Love, D.C., Krause, M.W. and Hanover, J.A. O-GlcNAc cycling: emerging roles in development and epigenetics. Semin. Cell. Dev. Biol. 21 (2010) 646–654. 10.1016/j.semcdb.2010.05.001Search in Google Scholar PubMed PubMed Central

[125] Hanover, J.A., Krause, M.W. and Love, D.C. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat. Rev. Mol. Cell. Biol. 13 (2012) 312–321. 10.1038/nrm3334Search in Google Scholar PubMed

[126] Leeb, M. and Wutz, A. Establishment of epigenetic patterns in development. Chromosoma 121 (2012) 251–262. Search in Google Scholar

[127] Richly, H., Aloia, L. and Di Croce, L. Roles of the Polycomb group proteins in stem cells and cancer. Cell. Death Dis. 2 (2011) e204. 10.1038/cddis.2011.84Search in Google Scholar PubMed PubMed Central

[128] Morey, L. and Helin, K. Polycomb group protein-mediated repression of transcription. Trends Biochem. Sci. 35 (2010) 323–332. Search in Google Scholar

[129] Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P. and Reinberg, D. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev. 16 (2002) 2893–2905. Search in Google Scholar

[130] Francis, N.J., Kingston, R.E. and Woodcock, C.L. Chromatin compaction by a polycomb group protein complex. Science 306 (2004) 1574–1577. Search in Google Scholar

[131] Tsang, D.P. and Cheng, A.S. Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. J. Gastroenterol. Hepatol. 26 (2011) 19–27. 10.1111/j.1440-1746.2010.06447.xSearch in Google Scholar PubMed

[132] Myers, S.A., Panning, B. and Burlingame, A.L. Polycomb repressive complex 2 is necessary for the normal site-specific O-GlcNAc distribution in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 108 (2011) 9490–9495. Search in Google Scholar

[133] Chu, C.S., Lo, P.W., Yeh, Y.H., Hsu, P.H., Peng, S.H., Teng, Y.C., Kang, M.L., Wong, C.H. and Juan, L.J. O-GlcNAcylation regulates EZH2 protein stability and function. Proc. Natl. Acad. Sci. USA. 111 (2014) 1355–1360. DOI: 10.1073/pnas.1323226111. 10.1073/pnas.1323226111Search in Google Scholar PubMed PubMed Central